Prenatal risk assessment of Xp21.1 duplication involving the DMD gene by optical genome mapping
Life Science Alliance · 2024
DOI: 10.26508/lsa.202402780 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Science Alliance, 2024. Verfasst von Yuanyuan Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Genetics, Shengjing Hospital of China Medical University, Shenyang, China. Hauptthemen laut MEDLINE: Pedigree, Dystrophin. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Liaoning Province, Science and Technology Foundation of Liaoning Province.
Abstract (Originalsprache)
Structural variants (SVs) of unknown significance are great challenges for prenatal risk assessment, especially when involving dose-sensitive genes such as DMD . The pathogenicities of 5′-terminal DMD duplications in the database remain controversial. Four prenatal cases with Xp21.1 duplications were identified by routine prenatal genomic testing, encompassing the 5′-UTR to exons 1–2 in family 1 and family 2, and to exons 1–9 in family 3. The duplication in family 4 was non-contiguous covering the 5′-UTR to exon 1 and exons 3–7. All were traced to unaffected males in the family pedigrees. A new genome-wide approach of optical genome mapping was performed in families 1, 2, and 3 to delineate the breakpoints and orientation of the duplicated fragments. The extra copies were tandemly inserted into the upstream of DMD , preserving the integrity of ORF from the second copy. The pathogenicities were thus reclassified as likely benign. Our data highlight the importance of structural delineation by optical genome mapping in prenatal risk assessment of incidentally identified SVs involving DMD and other similar large dose-sensitive genes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Clinical Genetics, Shengjing Hospital of China Medical University, Shenyang, China.
- Center of Reproductive Medicine, Shengjing Hospital of China Medical University, Shenyang, China.
- Department of Laboratory Medicine, Shengjing Hospital of China Medical University, Shenyang, China.
- Department of Orthopedics, Shengjing Hospital of China Medical University, Shenyang, China qiuc@sj-hospital.org.
- Department of Clinical Genetics, Shengjing Hospital of China Medical University, Shenyang, China liuxl@sj-hospital.org.
- Key Laboratory of Reproductive Health, Liaoning Research Institute of Reproductive Health and Development, Reproductive Hospital of China Medical University, Shenyang, China.
ORCID-Profile: Chuang Qiu, Xiaoliang Liu
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Liaoning Province
- Science and Technology Foundation of Liaoning Province
- General Project of Shengjing Hospital of China Medical University
Zitieren
APA
Zhang, Y., Du, Q., Gao, H., Pan, Y., Liu, N., Qiu, C., & Liu, X. (2024). Prenatal risk assessment of Xp21.1 duplication involving the DMD gene by optical genome mapping. Life Science Alliance. https://doi.org/10.26508/lsa.202402780
Vancouver
Zhang Y, Du Q, Gao H, Pan Y, Liu N, Qiu C, et al. Prenatal risk assessment of Xp21.1 duplication involving the DMD gene by optical genome mapping. Life Science Alliance. 2024. doi:10.26508/lsa.202402780
BibTeX
@article{Zhang2024,
author = {Zhang, Yuanyuan and Du, Qiang and Gao, Haiming and Pan, Yujie and Liu, Ningyang and Qiu, Chuang and Liu, Xiaoliang},
title = {Prenatal risk assessment of Xp21.1 duplication involving the DMD gene by optical genome mapping},
journal = {Life Science Alliance},
year = {2024},
doi = {10.26508/lsa.202402780}
}
EUVIMED